Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000321 · ClinicalTrials.gov registry record · Phase 4

Methamphetamine Abuse Treatment in Patients With AIDS - 1

A Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
Phase 4
Development phase

NCT00000321 is a Phase 4 study that has completed, run by National Institute on Drug Abuse (NIDA).

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000321, a Phase 4 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
Phase 4
Development phase

Study Summary

The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.

Interventions

  • DRUG Desipramine

Trial Details

FieldValue
Start Date 1996-10
Est. Completion 2001-12
Phase Phase 4

What the Registry Record Tells You About NCT00000321

The ClinicalTrials.gov registry entry for NCT00000321 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Desipramine is the first listed.

NCT00000321 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00000321 about?

NCT00000321 is a clinical study titled "Methamphetamine Abuse Treatment in Patients With AIDS - 1". The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.

What is the current status of trial NCT00000321?

This trial is currently completed. It is a Phase 4 study. The study started on 1996-10. Estimated completion is 2001-12.

What interventions are being tested in trial NCT00000321?

The interventions under investigation include: Desipramine (DRUG).

Who is sponsoring clinical trial NCT00000321?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.